Waterworks woes affecting your flow?

Are you 1 of the 2.8 million Aussie men aged 50+ years living with an enlarged prostate?^1-3

Did you know 1 in 2 men aged 50+ years will develop an enlarged prostate during their lifetime?⁴

Enlarged prostate symptoms are present in:⁴

of men aged 50

of men aged 60

of men aged 80

Waterworks problems are common

An enlarged prostate – a common and serious condition affecting older men^5,6 – involves a non-cancerous enlargement of the prostate gland and expansion of the surrounding tissues.^7,8

Effective treatment options for an enlarged prostate are available.⁹

Symptoms

An enlarged prostate can lead to lower urinary tract symptoms (LUTS), including:^10-12

An inability to completely empty the bladder when urinating

Difficulty starting and ending urination

Poor urine flow

Getting up at night to pass urine

An urgent need to pass urine

Passing urine more or less often
than usual

An enlarged prostate compresses the urethra, reducing urine flow from the bladder, and sometimes blocking it entirely.¹³

Don’t bury your head in the sand

Suffering in silence is not a solution

You don’t have to live with an enlarged prostate.
Click the link below to find a urologist specialising in the treatment of male urinary conditions, including an enlarged prostate.

Find a specialist

Learn what more than 1,000 Aussie men like you
have to say about living with an enlarged prostate¹⁴

Almost 2 in 3

men experience a compromised
quality of life

1 in 3

claim the condition has taken a toll on the relationship with their partner

1 in 2

men state it has
affected their
confidence

Sleep disruption

is a weekly challenge
for more than
3 in 4 men

3 in 10

claim the condition has affected their partner’s quality of life

For 2 in 5

men it has affected
their social life

Download the infographic

Importantly, an enlarged prostate is treatable⁹

If you are living with symptoms of an enlarged prostate, act now.

Symptoms may be treated by lifestyle changes, medication, minimally invasive techniques or surgical procedures.

Visit your doctor without delay.

Minimally invasive techniques¹⁵

Water vapour therapy

Prostatic urethral lift

Surgical procedures¹⁵

Transurethral resection of the prostate (TURP)

Photoselective vaporisation of the prostate (PVP)

Holmium laser enucleation of the prostate (HoLEP)

Rezūm Water Vapor Therapy

Rezūm water vapor therapy is a simple, short and minimally invasive procedure for an enlarged prostate. Taking less than 10 minutes to perform, most men return home the same day.¹⁶

Rezūm helps relieve symptoms, obstructions, and reduces prostate tissue associated with an enlarged prostate.

The treatment uses the natural energy stored in water vapour, or steam, to remove excess prostate tissue pressing on the urethra.

Over time, your body’s natural healing response absorbs the treated tissue, shrinking the prostate. With the extra tissue removed, the urethra opens, reducing enlarged prostate symptoms.

Surgery is required to use the Rezum™ System, and any surgical procedure carries risk. Outcomes may vary for each patient. Consult with your doctor to determine if the Rezum™ System is suitable for you and any factors that could impact your response.
THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.

Stories

Watch Dr Ethan’s story

Watch Barry’s story

s100 General Practitioner (GP) with a special interest in men’s health, Senior Lecturer, Faculty of Medicine, The University of Queensland (UQ), and Veterinarian, Dr Ethan, 60, Brisbane, was diagnosed with an enlarged prostate, in 2020, after experiencing lower urinary tract symptoms (LUTS) for two years.

Dr Ethan carried two risk factors for an enlarged prostate – ageing and a family history of the disease (all of his
uncles lived with an enlarged prostate).

Despite leading a very busy work and active physical life, Dr Ethan tolerated his symptoms for two years with incomplete bladder emptying, a weak urine stream, and eventually nocturia (frequent night-time urination).

Having managed many patients living with an enlarged prostate, Dr Ethan nonetheless, ignored his own symptoms, attributing them to “normal ageing” and “getting on with life”, because “that is what we, men my age, do.”

He commenced medications for an enlarged prostate, which initially provided temporary relief. However, over time, his nocturia continued to worsen.

“I started to get cranky. I have a busy and demanding job as a doctor, so waking up really tired after an awful
night’s sleep with nocturia, began to compromise my happy nature, and affected my evening gym sessions,” said
Dr Ethan.

Over time, Dr Ethan’s lower urinary tract symptoms took a huge toll on his physical and mental wellbeing.

Growing increasingly agitated by his nocturia, Dr Ethan finally decided to pursue a minimally invasive treatment option that
worked for him.

“Timely treatment for an enlarged prostate is so important.
“If you’re experiencing any enlarged prostate symptoms, please don’t be afraid to seek help,” Dr Ethan said.

Online business owner, father-to-five boys, and grandfather-to-three, Barry, 65, Orange, was diagnosed with an enlarged prostate, in 1999, after wrestling with initial symptoms of the condition for a year.

Aged 40 at the time, and with no known family history of an enlarged prostate, Barry was unaware of just how significantly the condition would eventually compromise his quality of life.

For the ensuing 25 years, Barry juggled significant family and work-related commitments along with progressive symptoms of an enlarged prostate – frequent, and incomplete bladder emptying; a weak urine flow; persistent urination throughout the night; and minimal control over bladder and bowel movements.

These symptoms proved “embarrassing and uncomfortable” for Barry whenever he prepared to leave home or socialise with friends. Over time his enlarged prostate symptoms imposed a heavy toll on his physical and mental wellbeing.

Eventually, after trialling a series of treatments over 25 years, Barry elected to undergo a minimally invasive treatment for his enlarged prostate.

References

Profile of Australia’s population: Australian Government – Australia Institute of Health and Welfare; 2024 [Available from: https://www.aihw.gov.au/reports/australias-health/profile-of-australias-population].
Population: Australian Bureau of Statistics; 2024 [Available from: https://www.abs.gov.au/statistics/people/population#:~:text=The%202021%20Census%20counted%2025%2C422%2C788,age%20of%2039%20years%20old.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline: American Urological Association 2023 [Available from: https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline].
Benign prostate hypertrophy: healthdirect; [Available from: https://www.healthdirect.gov.au/benign-prostate-hypertrophy].
Awedew AF, Han H, Abbasi B, Abbasi-Kangevari M, Ahmed MB, Almidani O, et al. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Healthy Longevity. 2022;3(11):e754-e76.
Understanding Prostate Changes and Conditions: National Cancer Institute 2024 [Available from: https://www.cancer.gov/types/prostate/understanding-prostate-changes#:~:text=The%20prostate%20is%20part%20of,the%20size%20of%20a%20lemon].
Franco JVA, Tesolin P, Jung JH. Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures. Prostate Int. 2023;11(1):1-7.
Benign prostate hyperplasia (BPH): Urology Care Foundation; 2023 [Available from: https://www.urologyhealth.org/urology-a-z/b/benign-prostatic-hyperplasia-(bph).
Morton A, Williams M, Perera M, Teloken PE, Donato P, Ranasinghe S, et al. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data. BJU Int. 2020;126 Suppl 1:18-26.
Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal DE, Jr., et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol. 2019;8(5):529-39.
Benign prostate hypertrophy: healthdirect; [Available from: https://www.healthdirect.gov.au/benign-prostate-hypertrophy].
Lepor H. Pathophysiology of lower urinary tract symptoms in the aging male population. Rev Urol. 2005;7 Suppl 7(Suppl 7):S3-s11.
Ng M, Leslie SW, Baradhi KM. Benign Prostatic Hyperplasia. StatPearls. Treasure Island (FL)2024.
Australian market research on benign prostatic hyperplasia (BPH). YouGov: YouGov; 2024.
Patel RM, Bariol S. National trends in surgical therapy for benign prostatic hyperplasia in Australia. ANZ J Surg. 2019;89(4):345-9.
McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, et al. Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of a Water Vapor Thermal Therapy for Treatment of Moderate to Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2021;206(3):715-24.

This material is for informational purposes only and not meant for medical diagnosis. This information does not constitute medical or legal advice, and Boston Scientific makes no representation regarding the medical benefits included in this information. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health. Content of this video is for information purposes only and does not constitute medical advice. Views and opinions expressed herein by third parties are theirs alone.

About YouGov market research
Boston Scientific commissioned YouGov to perform an online quantitative survey on benign prostatic hyperplasia (BPH), involving a nationally representative sample of 1,011 Australian men aged 50+ years between July 4 to 10, 2024.¹ The data was weighted by age and region to reflect the latest Australian Bureau of Statistics (ABS) population estimates of Australian men over 50 years of age.

CAUTION: Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. © 2024 Boston Scientific Corporation or its affiliates. All rights reserved. URO-2003110-AA OCT 2024.

Boston Scientific Pty Ltd, PO Box 332 Botany NSW 1455 Australia. Tel +61 2 8063 8100.